Clinical Trial Update: Fiix-prothrombin Time for Monitoring Warfarin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Fiix-prothrombin Time for monitoring Warfarin therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thromboembolism
• Venous Thromboembolism

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Landspitali University Hospital | Conditions: Thromboembolism, Arterial | Phase 2 | Status: COMPLETED